fbpx
https://blog.euromonitor.com/wp-content/uploads/2018/05/iconEMICroppedSquare-150x150.png

By: Chris Schmidt

Large pharmaceutical companies such as Pfizer and Sanofi are investing in the supplement category, a potential growth opportunity for pharmaceuticals. This category, once ignored by pharmaceutical companies, is almost as large as over-the-counter medication in terms of global retail sales. Chris Schmidt, Consumer Health Company Analyst at Euromonitor, cites several key areas of M&A activity in consumer health.

Download as an MP3

About Our Research

Request a complimentary demonstration of our award-winning market research today.